Chancellor Financial Group WB’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$334K Buy
5,792
+107
+2% +$6.14K 0.21% 101
2026
Q1
$345K Sell
5,685
-5,299
-48% -$309K 0.24% 79
2025
Q4
$592K Buy
10,984
+2,501
+29% +$120K 0.4% 50
2025
Q3
$383K Buy
8,483
+25
+0.3% +$1.17K 0.27% 72
2025
Q2
$392K Buy
8,458
+2,050
+32% +$101K 0.3% 67
2025
Q1
$391K Sell
6,408
-2,265
-26% -$132K 0.32% 66
2024
Q4
$491K Buy
+8,673
New +$485K 0.4% 53

Other funds holding BMY

Chancellor Financial Group WB's BMY Position: Q2 2026 in Review

Chancellor Financial Group WB increased its Bristol-Myers Squibb (BMY) stake by 1.9% in Q2 2026, buying an estimated $6.14K and bringing the position to 5,792 shares worth $334K. The position accounts for 0.21% of the portfolio, ranked #101.

Chancellor Financial Group WB first reported a position in BMY in Q4 2024 and has held it in 7 quarters since. The position peaked at $592K in Q4 2025. 2,521 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Chancellor Financial Group WB held 5,792 shares of Bristol-Myers Squibb worth $334K as of Q2 2026.
  • Chancellor Financial Group WB bought 107 Bristol-Myers Squibb shares in Q2 2026, an estimated $6.14K.
  • Bristol-Myers Squibb made up 0.21% of Chancellor Financial Group WB's portfolio in Q2 2026, its #101 holding.
  • Chancellor Financial Group WB first reported a position in Bristol-Myers Squibb in Q4 2024 and has held it in 7 quarters since.
  • Chancellor Financial Group WB's Bristol-Myers Squibb position peaked at $592K in Q4 2025.
  • 2,521 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Chancellor Financial Group WB's 13F filing for Q2 2026, filed 10 Aug 2026.